Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2009 June;21(2) > Minerva Biotecnologica 2009 June;21(2):123-34

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

  MOLECULAR IMAGING AND BIOTECHNOLOGY


Minerva Biotecnologica 2009 June;21(2):123-34

language: English

Technical and methodological issues in preclinical imaging with PET and SPECT

Lecchi M. 1,2, Belloli S. 3,4,5, Moresco R. M. 3,4,5, Lui R. 1,2, Del Sole A. 1,2, Fazio F. 3,4, Lucignani G. 1,2

1 Department of Biomedical Sciences and Technologies Section of Radiological Sciences University of Milan, Milan, Italy
2 Unit of Nuclear Medicine San Paolo Hospital, Milan, Italy
3 Nuclear Medicine Department and PET Centre San Raffaele Scientific Institute, Milan, Italy
4 University of Milano-Bicocca, Milan, Italy
5 IBFM-CNR, Milan, Italy


FULL TEXT  


Small-animal positron emission tomography (PET) and single photon emission tomography (SPECT) are invaluable tools in drug discovery and in assessing novel therapeutic agents. In a typical small-animal PET or SPECT imaging session, a radiopharmaceutical is administered and the kinetics of its distribution tracked. Whereas the PET and SPECT protocols for the radiotraceras used in clinical practice are well established, at least for the radiotracers that are used in clinical practice, the acquisition, reconstruction and data analysis procedures applied in small rodents are heterogeneous among centres, often being determined by the scanner characteristics and by the animal models and anaesthesia procedures used in the laboratory. This review, intended to serve as a guide to preclinical PET and SPECT experiments, aims to familiarise the reader with the aspects of PET and SPECT that pertain to in vivo preclinical acquisitions and, in particular, with the technical and methodological know-how that is needed for better application of radionuclide imaging techniques in preclinical cancer research.

top of page

Publication History

Cite this article as

Corresponding author e-mail